UFF
SUPN icon

USA Financial Formulas’s Supernus Pharmaceuticals SUPN Stock Holding History

USA Financial Formulas’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,051
Closed -$50.2K – 471
2025
Q3 		$50.2K Buy
+1,051
New +$42.3K 0.01% 223
2023
Q4 		– Sell
-3,438
Closed -$94.8K – 527
2023
Q3 		$94.8K Hold
3,438
– – 0.14% 154
2023
Q2 		$103K Sell
3,438
-185
-5% -$6.47K 0.16% 109
2023
Q1 		$131K Buy
+3,623
New +$139K 0.21% 68
2022
Q3 		$193K Buy
+5,713
New +$186K 0.3% 54
2017
Q4 		– Sell
-7,708
Closed -$308K – 336
2017
Q3 		$308K Buy
+7,708
New +$334K 0.07% 216

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return